Skip to main content
Retour
BRKR logo

Bruker Corporation

Qualité des données : 100%
BRKR
NASDAQ Healthcare Medical - Devices
35,80 €
▼ 0,01 € (-0,03%)
Cap. Boursière : 5,45B
Fourchette du Jour
34,82 € 37,00 €
Fourchette 52 Semaines
28,53 € 56,22 €
Volume
1 926 128
Moyenne 50J / 200J
42,01 € / 40,00 €
Clôture Précédente
35,81 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique Action Médiane du Secteur
P/E -633,7 0,2
P/B 2,2 3,0
ROE % -0,4 3,6
Net Margin % -0,3 3,8
Rev Growth 5Y % 9,2 10,0
D/E 0,8 0,2

Objectif de Cours des Analystes

Hold
52,13 € +45.6%
Low: 35,00 € High: 60,00 €
P/E Prévisionnel
16,90
BPA Prévisionnel
2,12 €
Croissance BPA (est.)
+0,0%
CA Est.
3,58B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 3,40 €
3,35 € – 3,44 €
4,24B 1
FY2029 3,11 €
3,07 € – 3,15 €
4,17B 1
FY2028 2,77 €
2,73 € – 2,80 €
3,92B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 0,65 € 0,59 € -9,2%
2025-11-03 0,33 € 0,60 € +81,8%
2025-08-04 0,33 € 0,32 € -3,0%
2025-05-07 0,46 € 0,47 € +2,2%
2025-02-13 0,75 € 0,76 € +1,3%
2024-11-05 0,61 € 0,60 € -1,6%
2024-08-06 0,52 € 0,52 € 0,0%
2024-05-02 0,46 € 0,53 € +15,2%

Dividend History

7 yr streak

Yield

0,00%

Payout Ratio

-2,65%

Growth (3Y)

0,00%

Growth (5Y)

4,56%

Ex-Date Payment Date Amount Yield
Mar 23, 2026 Apr 07, 2026 0,05 € 0,57%
Dec 08, 2025 Jan 02, 2026 0,05 € 0,43%
Sep 23, 2025 Oct 03, 2025 0,05 € 0,60%
Jun 16, 2025 Jun 27, 2025 0,05 € 0,51%
Mar 17, 2025 Mar 28, 2025 0,05 € 0,43%
Dec 02, 2024 Dec 16, 2024 0,05 € 0,34%
Aug 30, 2024 Sep 16, 2024 0,05 € 0,30%
Jun 03, 2024 Jun 17, 2024 0,05 € 0,31%
Feb 29, 2024 Mar 15, 2024 0,05 € 0,23%
Nov 30, 2023 Dec 15, 2023 0,05 € 0,31%
Aug 31, 2023 Sep 15, 2023 0,05 € 0,30%
May 31, 2023 Jun 16, 2023 0,05 € 0,29%
Feb 28, 2023 Mar 17, 2023 0,05 € 0,29%
Nov 30, 2022 Dec 16, 2022 0,05 € 0,30%
Aug 31, 2022 Sep 16, 2022 0,05 € 0,34%
May 31, 2022 Jun 17, 2022 0,05 € 0,29%
Feb 28, 2022 Mar 18, 2022 0,05 € 0,24%
Nov 30, 2021 Dec 17, 2021 0,04 € 0,20%
Aug 31, 2021 Sep 17, 2021 0,04 € 0,18%
May 28, 2021 Jun 18, 2021 0,04 € 0,23%

Points Clés

Revenue grew 9,19% annually over 5 years — modest growth
Earnings declined -107,60% over the past year
Generating 43,30M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,11%
Capital efficient — spends only 2,64% of revenue on capex
ROIC of 3,61% — low return on invested capital

Croissance

Revenue Growth (5Y)
9,19%
Revenue (1Y)2,08%
Earnings (1Y)-107,60%
FCF Growth (3Y)-57,80%

Qualité

Return on Equity
-0,41%
ROIC3,61%
Net Margin-0,25%
Op. Margin6,30%

Sécurité

Debt / Equity
0,83
Current Ratio1,73
Interest Coverage4,69

Valorisation

P/E Ratio
-633,66
Forward P/E16,90
P/B Ratio2,22
EV/EBITDA33,21
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2,08% Revenue Growth (3Y) 7,67%
Earnings Growth (1Y) -107,60% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9,19% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3,44B Net Income (TTM) -8,60M
ROE -0,41% ROA -0,14%
Gross Margin 45,61% Operating Margin 6,30%
Net Margin -0,25% Free Cash Flow (TTM) 43,30M
ROIC 3,61% FCF Growth (3Y) -57,80%
Safety
Debt / Equity 0,83 Current Ratio 1,73
Interest Coverage 4,69
Dividends
Dividend Yield 0,00% Payout Ratio -2,65%
Dividend Growth (3Y) 0,00% Dividend Growth (5Y) 4,56%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio -633,66 Forward P/E 16,90
P/B Ratio 2,22 P/S Ratio 1,59
PEG Ratio 6,94 Forward PEG N/A
EV/EBITDA 33,21 Fwd EV/EBITDA 11,79
Forward P/S 1,52 Fwd Earnings Yield 5,92%
FCF Yield 0,79%
Market Cap 5,45B Enterprise Value 7,19B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3,44B 3,37B 2,96B 2,53B 2,42B
Net Income -8,60M 113,10M 427,20M 296,60M 277,10M
EPS (Diluted) -0,15 0,76 2,90 1,99 1,81
Gross Profit 1,57B 1,65B 1,51B 1,31B 1,21B
Operating Income 216,60M 253,10M 436,90M 432,70M 413,30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,24B 5,81B 4,25B 3,61B 3,65B
Total Liabilities 3,73B 3,99B 2,84B 2,48B 2,57B
Shareholders' Equity 2,46B 1,78B 1,38B 1,11B 1,07B
Total Debt 2,04B 2,25B 1,38B 1,27B 1,39B
Cash & Equivalents 298,80M 183,40M 488,30M 645,50M 1,07B
Current Assets 2,21B 2,05B 2,16B 2,11B 2,47B
Current Liabilities 1,28B 1,28B 1,20B 914,30M 938,50M